DARIN STOCKTON: Open Payments
NPI 1689638652 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 66 payments from 21 companies in 2025. Trend: 2023 $1,117 · 2024 $845 · 2025 $1,207
Food & beverage: $1,207
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $219 |
| ABBVIE INC. | 12 | $209 |
| AstraZeneca Pharmaceuticals LP | 4 | $161 |
| Astellas Pharma US Inc | 4 | $65 |
| GlaxoSmithKline, LLC. | 4 | $59 |
| Abbott Laboratories | 3 | $56 |
| Amgen Inc. | 3 | $49 |
| Novo Nordisk Inc | 3 | $43 |
| Aimmune Therapeutics, Inc. | 2 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
Products named: FARXIGA, ELIQUIS, CREON, Veozah, PREVNAR 20, FREESTYLE LIBRE 3, NURTEC ODT, OTEZLA.
Industry payments across OK — which companies pay providers there.
